NN

Nadeera Nilupamali Sirisena Pahala Dickwellage

Director Director DIN 08474520
DIN 08474520 First appointment Jul 2019 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Jul 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Nadeera Nilupamali Sirisena Pahala Dickwellage

Data last updated:

Nadeera Nilupamali Sirisena Pahala Dickwellage was a Director at Immunifyme Healthcare Technologies Private Limited (2019–2024). The company operates in Healthcare.

DIN 08474520
Primary Designation Director
Industry Healthcare
First Appointment 10 Jul 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jul 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Immunifyme Healthcare Technologies Private Limited
Premium access

Shareholding and investment profile for Nadeera Nilupamali Sirisena Pahala Dickwellage

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nadeera Nilupamali Sirisena Pahala Dickwellage

Nadeera Nilupamali Sirisena Pahala Dickwellage was first appointed on 10 Jul 2019 as Director at Immunifyme Healthcare Technologies Private Limited.

Nadeera Nilupamali Sirisena Pahala Dickwellage held 1 earlier board appointment: Immunifyme Healthcare Technologies Private Limited (Director, 10 Jul 2019 to 04 Oct 2024).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available